首页> 外文期刊>Nature >Biotech funding deal judged to be 'a mistake' for Berkeley
【24h】

Biotech funding deal judged to be 'a mistake' for Berkeley

机译:生物技术融资交易被认为是伯克利的“错误”

获取原文
获取原文并翻译 | 示例
       

摘要

Large-scale partnerships between industry and universities ought to be avoided completely, according to the author of an external report investigating such a deal at the University of California at Berkeley. Although the arrangement provided cash that energized research, the report says, it created conflicts of interest within the university. The report was commissioned by the university's academic senate and conducted by Lawrence Busch, an agricultural sociologist at Michigan State University, East Lansing. It looks in detail at a controversial deal struck in 1998 between the university and a Swiss firm now known as Syngenta. The five-year agreement saw Syngenta contribute US$25 million to facilities and the funding of faculty at the university's department of plant and microbial biology, in exchange for the right to capitalize on their discoveries. The deal ended last year; Syngenta officials say it was abandoned owing to a change in company strategy.
机译:加州大学伯克利分校对这项交易进行调查的一份外部报告的作者说,应完全避免行业与大学之间的大规模合作。报告称,尽管这种安排提供了可促进研究的现金,但它在大学内部造成了利益冲突。该报告受大学学术院委托,由东兰辛市密歇根州立大学农业社会学家劳伦斯·布希(Lawrence Busch)撰写。它详细研究了1998年大学与瑞士公司(现称为先正达)之间有争议的交易。这份为期五年的协议使先正达公司为该大学的植物与微生物生物学系的设施和教职员工捐款2500万美元,以换取利用其发现的权利。该交易于去年结束;先正达公司的官员说,由于公司战略的改变,它被放弃了。

著录项

  • 来源
    《Nature》 |2004年第7000期|p.598|共1页
  • 作者

    Rex Dalton;

  • 作者单位

    San Diego;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 自然科学总论;
  • 关键词

  • 入库时间 2022-08-18 02:57:05

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号